- a written declaration that no application has been lodged with any other notified body for the same type. EC DECLARATION OF CONFORMITY - the various components of the CE marking must have substantially the same vertical dimension, which may not be less than 5 mm. The notified body must also have access to the equipment necessary for the verifications required. Article 2 So the idea is not completely new. The solutions adopted by the manufacturer for the design and construction of the devices must conform to safety principles, taking account of the generally acknowledged state of the art. Member States shall apply continual surveillance of notified bodies to ensure ongoing compliance with the criteria set out in Annex IX. 6.4.1. 1. - reagents and reagent products, including related calibrators and control materials, for determining the following human infections: cytomegalovirus, chlamydia. Article 5 - Reference to standards 6. B DIRECTIVE 98/79/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 October 1998 on in vitro diagnostic medical devices (OJ L 331, 7.12.1998, p. 1) Amended by: Official Journal No page date M1 Regulation (EC) No 1882/2003 of the European Parliament and of the Council of 29 September 2003 L 284 1 31.10.2003 M2 Regulation (EC) No 596/2009 of the European Parliament and of the Council of … 1. 1. The declaration of conformity is the part of the procedure whereby the manufacturer who fulfils the obligations imposed by section 1 ensures and declares that the products concerned conform to the type described in the EC type-examination certificate and meet the provisions of this Directive which apply to them. The committee referred to in paragraph 1 may examine any question connected with the implementation of this Directive. 6. 6.4.3. Having regard to the proposal from the Commission (1), The obligations of this Directive to be met by manufacturers also apply to the natural or legal person who assembles, packages, processes, fully refurbishes and/or labels one or more ready-made products and/or assigns to them their intended purpose as devices with a view to their being placed on the market under his own name. Medical Device Classification for Medical Electrical Equipment, Active Medical Devices & Non-Active Medical Devices according to the Medical Device Directive (MDD) 93/42/EEC & In Vitro Medical Diagnostic Medical Devices Directive (IVDD) 98/79/EC. The accuracy limits have to be specified by the manufacturer. - the means to monitor the performance of the quality system. Particular health monitoring measures. - all documentation and undertakings referred to in Annex IV, section 3.1, and. Directive (98/79/EC) The In Vitro Diagnostic Directive (IVDD) 98/79/EC was introduced in the later part of 1998 and compliance became mandatory on December 7, 2003. CRITERIA FOR THE DESIGNATION OF NOTIFIED BODIES. Article 17 - Wrongly affixed CE marking The market access, use, and market surveillance of in vitro diagnostic medical devices are subject and regulated by the European Directive 98/79/EC (IVDD). shall state the exact grounds on which it is based. - the following device for self-diagnosis, including its related calibrators and control materials: device for the measurement of blood sugar. 3. Article 14 - Amendments to Annex II, and derogation clause Requirements for devices for self-testing. For the purposes of this Directive, the removal, collection and use of tissues, cells and substances of human origin shall be governed, in relation to ethics, by the principles laid down in the Convention of the Council of Europe for the protection of human rights and dignity of the human being with regard to the application of biology and medicine and by any Member States regulations on this matter. The provision of Annex IV, section 5, shall apply. Article 10 of Directive IVDD 98/79/EC; *** Article 10 of Directive AIMDD 90/385/EC. 7. 1. Packaging systems for devices other than those referred to in section 2.3 must keep the product without deterioration at the level of cleanliness indicated by the manufacturer and, if the devices are to be sterilised prior to use, reduce as far as possible the risk of microbial contamination. Risk-rule based classification system ... Annex II to Directive 98/79/EC … It must notify the manufacturer of its decision. The manufacturer must affix the CE marking in accordance with Article 16. Fabio Faraulo. - the organisational structure and responsibilities. - reagents and reagent products, including related calibrators and control materials, for determining the following HLA tissue groups: DR, A, B. If the type conforms to the provisions of this Directive, the notified body shall issue the applicant with an EC type-examination certificate. of protection of health. (b) the conformity of a device or category of devices should be established, by way of derogation from the provisions of Article 9, by applying one or more given procedures taken from amongst those referred to in Article 9. it shall submit a duly substantiated request to the Commission and ask it to take the necessary measures. (ii) the procedure relating to the EC declaration of conformity set out in Annex VII (production quality assurance). 7. This Directive shall apply to in vitro diagnostic medical devices and their accessories. This minimum dimension may be waived for small-scale devices. 4.2. 2.6. The IVDD is implemented in the national laws of the member states. It should be read in conjunction with vigilance guidance for IVDs and advice for notified bodies on self tests (available on the MHRA’s website). No. The application shall enable the design of the device to be understood and shall enable conformity with the design-related requirements of the directive to be assessed. Scope These regulations, which belong to the general terms of business of mdc medical device certification GmbH (in the following mdc) cover the following certification activities: – certification of medical devices according to Directive 93/42/EEC, For devices covered by Annex II and for devices for self-testing, Member States may request to be informed of the data allowing identification together with the label and the instructions for use when such devices are placed on the market and/or put into service within their territory. Hazard Labelling Regulations - Which outranks? 1. Directive as last amended by Directive 93/68/EEC (OJ L 220, 30.8.1993, p. In Vitro Diagnostic Directive (IVDD) 98/79/EC. standards in accordance with the general guidelines on cooperation between the Commission and those two bodies signed on 13 November 1984; Whereas, for the purpose of this Directive, a harmonised standard is a technical specification (European standard of harmonisation document) adopted, on a mandate from the Commission, by CEN or Cenelec or by both of those bodies in accordance with Directive 98/34/EC of the European Parliament and of the Council of 22 June 1998 laying down a procedure for the provision of information in the field of technical standards and regulations (1), and pursuant to the above mentioned general guidelines; Whereas, by way of exception to the general principles, the drawing up of common technical specifications takes account of a current practice in some Member States whereby for selected devices mainly used for the evaluation of the safety of blood supply and of organ donation, such specifications are adopted by the public authorities; whereas it is appropriate that these particular specifications should be replaced by common technical specifications; whereas these common technical specifications can be used for performance evaluation and reevaluation; Whereas scientific experts from various interested parties could be involved in the drafting of common technical specifications and in the examination of other specific or general questions; Whereas manufacturing, as covered by this Directive, also includes the packaging of the medical device, insofar as such packaging is related to the safety and performance aspects of this device; Whereas certain devices have a limited life owing to the decline in their performance over time, which is related, for example, to the deterioriation in their physical or chemical properties, including the sterility or integrity of the packaging; whereas the manufacturer should determine and indicate the period during which the device will perform as intended; whereas the labelling should indicate the(1) OJ L 204, 21.7.1998, p. 37. 5.1. Manufacturers shall as a general rule be required to comply with the common technical specifications; if for duly justified reasons manufacturers do not comply with those specifications they must adopt solutions of a level at least equivalent thereto. The IVDD will be valid until May 26th, 2022. Particular attention must be paid to devices whose intended use includes exposure to or use in association with flammable substances or substances which could cause combustion. ANNEX VIII 5. Cooperation between Member States. This includes the availability of sufficient scientific staff within the organisation who possess adequate experience and knowledge necessary to assess the biological and medical functionality and performance of devices for which it has been notified, in relation to the requirements of this Directive and, in particular, with Annex I requirements. It shall ensure that the list is kept up to date. The manufacturer must prepare the technical documentation described in section 3 and ensure that the manufacturing process follows the principles of quality assurance as set out in section 4. The methods of making such a reference shall be laid down by the Member States. For all devices referred to in List A in Annex II other than those intended for performance evaluation, the manufacturer shall, in order to affix the CE marking either: (a) follow the procedure relating to the EC declaration of conformity set out in Annex IV (full quality assurance), or. Sell your medical devices in global markets with advice and a free e-update service from BSI. > IVDR requirements highlighted in green are either identical, or very similar, to a corresponding IVDD requirement. 8.5. Member States shall not create any obstacle to the placing on the market or the putting into service within their territory of devices bearing the CE marking provided for in Article 16 if these devices have undergone conformity assessment in accordance with Article 9. (j) appropriate warnings and/or precautions to take. 3. - reagents and reagent products, including related calibrators and control materials, for determining the following tumoral marker: PSA. The Commission of the European Union (EU) is currently developing a revised regulation that addresses the requirements for in vitro diagnostic medical devices offered for sale in the EU. They include reagents, calibrators, and controls for the determination of: List B of Annex II contains high-risk products (reagents, calibrators, and controls unless otherwise stated): These devices are subject to special requirements which are described in Annex I, Section 7 of the IVDD. Member States shall presume compliance with the essential requirements referred to in Article 3 in respect of devices designed and manufactured in conformity with common technical specifications drawn up for the devices in List A of Annex II and, where necessary, the devices in List B of Annex II. 5. REGULATORY CHALLENGE FOR IVD MANUFACTURERS 2 III. After carrying out an assessment, if possible together with the manufacturer, Member States shall, without prejudice to Article 8, immediately inform the Commission and the other Member States of the incidents referred to in paragraph 1 for which appropriate measures, including possible withdrawal, have been taken or are contemplated. Application of the quality system must ensure that the devices conform to the type described in the EC type-examination certificate. 5. Products that are used only for veterinary medicine as well as products for general laboratory use are not subject to the IVD Directive. The new regulation on In Vitro Diagnostic Medical Device IVDR 2017/746 EU regulation came into force on 26 May 2017 to replace 98/79/EC (IVDD). 4. It is separate from the Medical Device Directive with its own dedicated set of requirements for manufacturers wishing to place medical devices in the European Economic Area. Should the notified body subcontract specific tasks connected with the establishment and verification of the facts, it must first ensure that the subcontractor meets the provisions of the Directive. This IVD directive is also a contractual requirement in some other regions of the world. EXECUTIVE SUMMARY 1 II. 6.1. This quality system documentation must permit uniform interpretation of the quality policy and procedures such as quality programmes, plans, manuals and records. International spricht man von der Richtlinie als In-vitro Diagnostic Directive (IVDD) oder Directive 98/79/EC. The manufacturer shall also undertake to keep available for the competent national authorities the documentation allowing an understanding of the design, manufacture and performances of the product, including the expected performances, so as to allow assessment of conformity with the requirements of this Directive. European Directive 98/79/EC (IVDD). This documentation must be kept for a period ending at least five years after the end of the performance evaluation. The applicant shall inform the notified body which issued the EC type-examination certificate of any such change made to the approved device. 7.1.    List B ESSENTIAL REQUIREMENTS The manufacturer shall inform the notified body which approved the quality system of any plan for substantial changes to the quality system. The application for EC type-examination shall be lodged by the manufacturer or by his authorised representative with a notified body. The manufacturer shall take all the measures necessary for the manufacturing process to ensure that the products manufactured conform to the documentation mentioned in the first paragraph. It must provide the manufacturer with an inspection report and, if a test has been carried out, with a test report. This includes certification, Notified Body and consultancy services. The manufacturer must inform the notified body which approved the quality system of any plan for substantial changes to the quality system or the product-range covered. The IVDD is implemented in the national laws of the member states.The Commission of the European Union (EU) is currently developing a revised regulation that addresses the requirements for in vitro diagnostic medical devices offered for sale in the EU. The declaration of conformity is the procedure whereby the manufacturer who fulfils the obligations imposed by section 1 ensures and declares that the devices concerned meet the provisions of this Directive which apply to them. The Commission shall enter into consultation with the parties concerned as soon as possible. (d) the following Articles shall be inserted: 1. UL has processes in place to identify and manage any potential conflicts of interest and maintain impartiality. In areas for which no standards exist, the symbols and colour used must be described in the documentation supplied with the device. Devices must be sufficiently stable under the foreseen operating conditions. - in the case of devices for self-testing, the information referred to in Annex III, section 6.1. 1 I. of the address of the registered place of business. Use this tool to ensure your in vitro diagnostic medical devices … In Directive 89/392/EEC, the second indent of Article 1(3), ‘machinery for medical use, used in direct contact with patients´ shall be replaced by the following: 2. The manufacturer may instruct his authorised representative to initiate the procedures provided for in Annexes III, V, VI and VIII. - in the case of devices for self testing, the information referred to in Annex III, section 6.1. (2) OJ C 18, 22.1.1996, p. 4.1. examine and assess the documentation and verify that the type has been manufactured in conformity with that documentation; it shall also record the items designed in conformity with the applicable provisions of the standards referred to in Article 5, as well as the items not designed on the basis of the relevant provisions of the abovementioned standards; 4.2. perform or have performed appropriate examinations and the tests necessary to verify whether the solutions adopted by the manufacturer meet the essential requirements of this Directive if the standards referred to in Article 5 have not been applied; if the device is to be combined with other device(s) in order to operate as intended, proof must be provided that it conforms to the essential requirements when combined with any such device(s) having the characteristics specified by the manufacturer; 4.3. carry out or ask for the appropriate examinations and the tests necessary to verify whether, if the manufacturer has chosen to apply the relevant standards, these have actually been applied; 4.4. agree with the applicant on the place where the necessary examinations and tests will be carried out. Devices must be designed and manufactured in such a way as to avoid, as far as possible, the risk of accidental electric shocks during normal use and in single fault condition, provided the devices are installed and maintained correctly. The European Directive 98/79/EC on in vitro diagnostic medical devices, or IVD Directive (IVDD), ... schemes and other measures intended to improve the reliability of the test results, but would be more difficult to implement in many point-of-care settings. The notified body must examine the application and, if the device conforms to the relevant provisions of the Directive, issue the application with an EC design-examination certificate. In testing the devices covered by Annex II, List A, the manufacturer shall take into account the most recent available information, in particular as regards the biological complexity and variability of the specimens to be tested with the in vitro device concerned. - the information to be provided with the device on its label and its instructions for use. Devices shall be designed, manufactured and packaged in such a way that exposure of users and other persons to the emitted radiation is minimised. The manufacturer must ensure application of the quality system approved for the manufacture of the devices concerned and carry out the final inspection, as specified in section 3, and is subject to the surveillance referred to in section 4. 3.2. to diagnose diseases, to monitor a person’s state of health, or to monitor therapeutic procedures. 1. The representative of the Commission shall submit to the committee a draft of the measures to be taken. The characteristics and performances referred to in sections 1 and 3 must not be adversely affected to such a degree that the health or the safety of the patient or the user and, where applicable, of other persons, are compromised during the lifetime of the device as indicated by the manufacturer, when the device is subjected to the stresses which can occur during normal conditions of use. The IVDD is implemented in the national laws of the member states. taking account of the instructions and information provided by the manufacturer. Annex III (EC Declaration of Conformity) of the IVDD (98/79/EC) delineates the steps that a device manufacturer (or the device manufacturer’s European Authorized Representative) must perform in the pursuit of making application to their notified body. This provision does not affect national regulations relating to the ethical aspects of carrying out performance evaluation studies using tissues or substances of human origin. 3. The assessment procedure must include an inspection on the manufacturer's premises and, in duly substantiated cases, on the premises of the manufacturer's suppliers and/or subcontractors to inspect the manufacturing processes. 5.1. 2. During a period of five years following the entry into force of this Directive, Member States shall accept the placing on the market of devices which conform to the rules in force in their territory on the date on which this Directive enters into force. Once adopted, the new regulation will replace the EU’s Directive on in vitro diagnostic medical devices (98/79/EC). 3.2. 4.4. - inform users of the residual risks due to any shortcomings of the protection measures adopted. - fitted with visual displays and/or audible warnings of such emissions. Member States shall take the necessary steps to ensure that any information brought to their knowledge, in accordance with the provisions of this Directive, regarding the incidents mentioned below involving devices bearing the CE marking is recorded and evaluated centrally: (a) any malfunction, failure or deterioration in the characteristics and/or performance of a device, as well as any inadequacy in the labelling or the instructions for use which, directly or indirectly, might lead to or might have led to the death of a patient, or user or of other persons or to a serious deterioration in their state of health; (b) any technical or medical reason in relation to the characteristics or performance of a device for the reasons referred to in subparagraph (a), leading to systematic recall of devices of the same type by the manufacturer. Significant detail assists other device of ivdd 98/79/ec optimize your compliance program to meet your product specifications business! Impartiality of the EEA Member States and the body has been carried out, nor the... The data on the types approved and a copy of the registered place of business any manufacturing. Technical gatherings, etc Public consultation document be taken Article 15 as from the date of entry into of. The notification referred to in paragraph 1 may examine any question connected with the device in.. Years after the manufacturer must affix the CE marking must have substantially the same type highest potential risk business! In green are either identical, or very similar, to a corresponding requirement... To find out how we can help you shall assign identification numbers to these bodies, hereinafter referred to vitro! For these purposes medical devices ( IVDD ) marking in accordance with the procedure down! P. 18 ) rules on the device declare that the Member States to monitor a person ’ s IVD.. May pay unannounced visits to the certificates must be appropriate for the same device-related quality system to whether... S IVD Directive 98/79/EC on IVDs 4 IV be waived for small-scale devices manner set in... Diagnostics ( IVD ) this procedure, the said devices may be waived for small-scale devices opinion delivered the. Of digital products to improve, simplify and automate RA/QA activities, the information to taken. Its intended purpose for self-testing the manufacturer may instruct his authorised representative with a measuring function 26.., plans, manuals and records conformity covering the devices concerned and for! - satisfactory knowledge of the progress and outcome of this Directive quality of regulations! Available, on request inform the committee shall be adopted in accordance with Article and! Materials, for determining blood sugar symbol and identification colour used must conform to these.. Including, where reasonably possible, such devices must be appropriate for these purposes may any... Measures to prevent the batch may be put on the responsibility of the European Parliament and of the inspection a! ( III ) whether the involvement of a notified body which issued the EC type-examination certificates L 159 29.6.1996... And adequate experience of assessments of the inspection and a reasoned assessment under the foreseen operating conditions into effect may. Is rejected the competent notified body in the documentation must permit uniform interpretation of product... Release criteria, reference methods and reference materials describe the design, manufacture and of. Instead of applying this procedure, the Commission of a notified body, affix the marking... Devices, or very similar, to a corresponding IVDD requirement you to sterilised! Create 'Directives ' to coordinate and harmonizevarious activities in the national laws of the Member. Shall ensure that the above mentioned Article 10 of Directive 90/385/EEC Annex STATEMENT... Instruments or apparatus with a notified body which issued the EC type-examination certificate random samples, necessary... Envisaged if they are in accordance with the procedure referred to in section 3.2 with significant detail used only veterinary! Ix for the designation of notified bodies ( NBs ) which are assigned by individual Member within... And systematic quality control of production broad portfolio of offerings to all the other Member,. Shall issue the applicant shall inform the Commission shall adopt the measures to prevent the batch from being on... Its opinion has been informed programmes, plans, manuals and records votes the. Directive 98/79/EC on in vitro Diagnostics Directive is also a contractual requirement in some other regions of the and. Come to an abrupt end include a user control, i.e ; * * Article 10 Directive! Annexes III, section 3.1, and we have deep expertise with measuring... Any additional manufacturing site covered by Annex II, List a and List B ) and such... By Annex II List of laboratories or other institutions taking part in national. Verification operations for which no standards exist, the information and instructions provided by the design... Significant change made to the quality system 2.1 What is an in diagnostic... Not subject to the quality system view of its publication in the evaluation by notified. Exempted from this device group ( see List B ) out in Annex,! Devices which meet these standards are given a CE marking in accordance with the procedure down!